Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardiac dysfunction in cirrhosis.

Ralph F Lee1, Tamara K Glenn, Samuel S Lee

  • 1Liver Unit, University of Calgary, Calgary, AB, Canada.

Best Practice & Research. Clinical Gastroenterology
|January 16, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dendrite initiation and deflection in biaxially stressed solid electrolytes.

Nature·2026
Same author

A Gender-Based Descriptive Analysis of the Canadian Network Undertaking Against Hepatitis C (CANUHC) Cohort From 2015-2023.

Open forum infectious diseases·2026
Same author

Impact of gastrectomy on the risk of alcohol-associated liver disease in patients with gastric cancer.

Scientific reports·2026
Same author

Heterogeneous doping via nanoscale coating impacts the mechanics of Li intrusion in brittle solid electrolytes.

Nature materials·2026
Same author

Prevalence of cirrhotic cardiomyopathy in liver transplant candidates: Impact on pre- and post-transplant mortality.

Annals of hepatology·2025
Same author

Empagliflozin for non-diabetic metabolic dysfunction-associated steatotic liver disease: a promising therapeutic agent in transition.

Hepatobiliary surgery and nutrition·2025

Cirrhosis causes cardiac abnormalities, termed cirrhotic cardiomyopathy, affecting heart function and electrical stability. Understanding its mechanisms is key for managing liver disease complications.

Area of Science:

  • Cardiology
  • Hepatology
  • Pharmacology

Background:

  • Cirrhosis is linked to cardiovascular issues like increased cardiac output and reduced arterial pressure.
  • Patients with cirrhosis exhibit impaired systolic and diastolic function under stress, alongside electrical abnormalities like QT prolongation.
  • These cardiac dysfunctions are collectively known as cirrhotic cardiomyopathy.

Purpose of the Study:

  • To review the clinical features of cirrhotic cardiomyopathy.
  • To discuss the pathogenic mechanisms underlying this condition.
  • To explore the clinical consequences and management strategies for cirrhotic cardiomyopathy.

Main Methods:

  • This is a review article.
  • It synthesizes existing literature on cirrhotic cardiomyopathy.

Related Experiment Videos

  • Key pathogenic mechanisms and clinical implications are discussed.

    • Main Results:

    • Cirrhotic cardiomyopathy involves impaired beta-adrenergic signaling, cardiomyocyte membrane dysfunction, altered calcium kinetics, and humoral factors.
    • It contributes to cardiac dysfunction post-transjugular intrahepatic portosystemic stent-shunt insertion and liver transplantation.
    • It may also play a role in hepatorenal syndrome development.

    Conclusions:

    • Cirrhotic cardiomyopathy is a significant complication of cirrhosis with diverse pathogenic mechanisms.
    • It impacts patient outcomes, particularly after procedures like liver transplantation.
    • Further research into management options is warranted.